Bladder Cancer - Liquid biopsies could help identify, track bladder cancer and peripheral nerve tumors
Can't see this email? View it online
   
  Bladder Cancer  
  The latest bladder cancer news from News Medical  
 Immunotherapy after bladder cancer surgery helps reduce cancer recurrenceImmunotherapy after bladder cancer surgery helps reduce cancer recurrence
 
Immunotherapy after surgery helped reduce cancer recurrence in patients with urothelial cancer of the bladder or other sites in the urinary tract that had invaded the muscle and therefore posed a high risk for recurrence, according to clinical trial results presented at the American Urological Association annual meeting in May.
 
   Liquid biopsies could help identify, track bladder cancer and peripheral nerve tumorsLiquid biopsies could help identify, track bladder cancer and peripheral nerve tumors
 
Liquid biopsies detect tumor DNA in blood or urine samples. Two studies led by Washington University School of Medicine in St. Louis describe the potential of liquid biopsies to identify and track tumor growth in two very different cancers: bladder cancer and peripheral nerve tumors.
 
   Biomarker could predict pathologic response to chemotherapy among bladder cancer patientsBiomarker could predict pathologic response to chemotherapy among bladder cancer patients
 
Long-term survival data from the first prospective, randomized biomarker validation trial in patients with muscle-invasive bladder cancer being treated with cisplatin-based chemotherapy before surgery will be reported at the 2022 Genitourinary Cancers Symposium of the American Society of Clinical Oncology (GU ASCO) on February 18, 2022.
 
 Study reveals urine protein biomarkers of bladder cancer
 
Study reveals urine protein biomarkers of bladder cancerOncotarget published "Urine protein biomarkers of bladder cancer arising from 16-plex antibody-based screens" which reported that the current study examines urine samples from 66 subjects, comprising of 31 Urology clinic controls and 35 bladder cancer patients, using a Luminex based screening platform.
 
 
 Blood test may help identify risk of bladder cancer recurrence after surgery
 
Blood test may help identify risk of bladder cancer recurrence after surgeryA blood test that can detect tiny amounts of circulating cancer DNA may be able to identify risk of cancer recurrence and guide precision treatment in bladder cancer following surgery, according to a clinical study led byProfessor Tom Powles from Queen Mary University of London andBarts Health NHS Trust.
 
 
 Novel drug combination can boost chemoimmunotherapy response in bladder cancer patients
 
Novel drug combination can boost chemoimmunotherapy response in bladder cancer patientsAdding an anti-inflammatory medication to immunotherapy and standard chemotherapy drugs may provide long-term suppression of aggressive bladder tumor growth, according to a proof-of-concept study led by Cedars-Sinai Cancer investigators.
 
 
 Drug used to treat lung cancer could help improve survival rates for bladder cancer patients
 
Drug used to treat lung cancer could help improve survival rates for bladder cancer patientsScientists from the University of Sheffield have discovered a drug already used to treat lung cancer could help to improve survival rates for bladder cancer patients.